Leica Laser Microdissection Microscope for a Shared Resource
共享资源的徕卡激光显微切割显微镜
基本信息
- 批准号:8448032
- 负责人:
- 金额:$ 25.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-18 至 2014-06-17
- 项目状态:已结题
- 来源:
- 关键词:AIDS related cancerAcuteAddressBeta CellBiologyCachexiaCell Culture TechniquesCellsChairpersonChronicComputer softwareDissectionFee-for-Service PlansFistulaFloridaFluorescenceFundingGenomicsGrantImmuneImmune responseImmunologyInflammationInflammatoryInstitutionInsulin-Dependent Diabetes MellitusLaboratoriesLasersLupusLymphocyteMaintenanceMedicineMicrodissectionMicroscopeMitochondriaModelingNatural regenerationOperative Surgical ProceduresPathologyPopulationProcessRequest for ProposalsResearchResearch PersonnelResearch TechnicsResource SharingSamplingScienceSepsisSepsis SyndromeTechniquesTissuesTrainingTransplantation ImmunologyTubeUnited States National Institutes of HealthUniversitiesVenousWorkcollegeexperienceflexibilityglucose metabolisminstrumentinstrumentationisletlaser capture microdissectionmolecular pathology
项目摘要
DESCRIPTION (provided by applicant): Laser capture microdissection has become a primary research technique to isolate specific cell populations from tissues or cell culture affording further sub-cellular techniques to be conducted on highly purified cells rather than a heterogeneous tissue. This proposal requests support for the purchase of a Leica LMD7000 laser capture microscope, to be maintained in an institutional Shared Resource, the Molecular Pathology Core. Access to this instrumentation is crucial to the work of two major user groups, namely, Center for Immunology and Transplantation and Laboratory of Inflammation Biology and Surgical Sciences, at the University of Florida. Administration, maintenance, and high-level technical assistance and training will be provided by experienced staff in the Molecular Pathology Core. All user training and biosafety issues have been addressed. Strong institutional commitment is demonstrated by the support of College of Medicine Dean, Dr. Michael Good, and Senior Associate Dean, Dr. Steven Sugrue, and Department of Pathology, Immunology and Laboratory Medicine Chairman, Dr. Michael Clare-Salzler. The Leica LMD7000 was selected as the most suitable for a multi-user facility due to its greater flexibility for a wide range of sampe types and clearly fulfills an unmet need as the institution does not have this instrumentation available through a shared resource. The Leica instrument has several ideal features including intuitive and simple software to automate sample dissection, 4-tube extraction capabilities, brightfield and fluorescence, cell culture, and superior objectives for sharp laser cutting. The major users highlighted in this proposal are well-funded by the NIH with active and pending grants requiring this instrumentation. Each would benefit greatly from having institutional access to a laser capture instrument. Martha Campbell-Thompson and Mark Atkinson will use the LMD7000 to study infiltrating lymphocytes and islets to understand mechanisms of beta cell destruction and islet regeneration for type 1 diabetes. Clayton Mathews will conduct research on the basic biology of mitochondria in beta cells and altered glucose metabolism through genomic analyses of isolated islets. Laurence Morel studies various immune cell populations in a model of systemic lupus and is currently subcontracting the laser capture studies to a collaborator at another institution. Lyle Moldawer studies host responses to acute inflammatory processes in sepsis and systemic inflammatory response syndromes and to chronic inflammatory processes, including cancer and AIDS-associated cachexia. He too has active NIH funding for studies with laser capture microdissection for arterial venous fistula. Finally, the instrument will be availabl to other investigators through this shared resource using a fee-for-service mechanism for training and assisted or unassisted use.
描述(由申请人提供):激光捕获显微切割已成为从组织或细胞培养物中分离特定细胞群的主要研究技术,可在高度纯化的细胞而不是异质组织上进行进一步的亚细胞技术。该提案要求支持购买Leica LMD 7000激光捕获显微镜,并将其保存在机构共享资源“分子病理学核心”中。 获得这种仪器对两个主要用户组的工作至关重要,即佛罗里达大学免疫学和移植中心以及炎症生物学和外科科学实验室。 管理、维护和高水平技术援助和培训将由分子病理学中心经验丰富的工作人员提供。所有用户培训和生物安全问题都已得到解决。强有力的机构承诺是由医学院院长,博士迈克尔好,和高级副院长,博士史蒂芬Sugrue,和病理学,免疫学和实验室医学系主席,博士迈克尔克莱尔Salzler的支持证明。Leica LMD 7000被选为最适合多用户机构的仪器,因为它具有更大的灵活性,适用于各种样品类型,并且明显满足了未满足的需求,因为该机构没有通过共享资源提供这种仪器。Leica仪器具有几个理想的功能,包括直观简单的软件,可自动进行样品切割,4管提取功能,明场和荧光,细胞培养,以及用于锐利激光切割的上级物镜。本提案中强调的主要用户由NIH提供充足的资金,并获得了需要该仪器的积极和待定的赠款。每个机构都将从机构获得激光捕获仪器中受益匪浅。Martha Campbell-Thompson和Mark Atkinson将使用LMD 7000研究浸润淋巴细胞和胰岛,以了解1型糖尿病β细胞破坏和胰岛再生的机制。克莱顿马修斯将进行研究的基本生物学线粒体在β细胞和改变葡萄糖代谢通过基因组分析分离胰岛。Laurence Morel研究了系统性狼疮模型中的各种免疫细胞群,目前正在将激光捕获研究分包给另一家机构的合作者。Lyle Moldawer研究了脓毒症和全身炎症反应综合征中宿主对急性炎症过程的反应,以及对慢性炎症过程的反应,包括癌症和艾滋病相关的恶病质。他也有国家卫生研究院的积极资助,用于动脉静脉瘘的激光捕获显微切割研究。最后,该工具将通过这一共享资源提供给其他调查人员,并采用收费服务机制进行培训和辅助或无辅助使用。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARTHA CAMPBELL-THOMPSON其他文献
MARTHA CAMPBELL-THOMPSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARTHA CAMPBELL-THOMPSON', 18)}}的其他基金
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
了解 1 型糖尿病前期的胰腺内分泌和外分泌丧失
- 批准号:
10461979 - 财政年份:2020
- 资助金额:
$ 25.2万 - 项目类别:
Multi-omic 3D tissue maps for a Human BioMolecular Atlas
人类生物分子图谱的多组学 3D 组织图谱
- 批准号:
10685583 - 财政年份:2020
- 资助金额:
$ 25.2万 - 项目类别:
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
了解 1 型糖尿病前期的胰腺内分泌和外分泌丧失
- 批准号:
10226911 - 财政年份:2020
- 资助金额:
$ 25.2万 - 项目类别:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
1 型糖尿病早期 β 细胞功能障碍的途径和关键调节因子
- 批准号:
10202585 - 财政年份:2019
- 资助金额:
$ 25.2万 - 项目类别:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
1 型糖尿病早期 β 细胞功能障碍的途径和关键调节因子
- 批准号:
10441263 - 财政年份:2019
- 资助金额:
$ 25.2万 - 项目类别:
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
1 型糖尿病早期 β 细胞功能障碍的途径和关键调节因子
- 批准号:
9802936 - 财政年份:2019
- 资助金额:
$ 25.2万 - 项目类别:
Neuromodulation-based treatment of diabetes: identifying anatomical and physiological pancreatic innervation targets
基于神经调节的糖尿病治疗:确定解剖学和生理学胰腺神经支配目标
- 批准号:
9752693 - 财政年份:2016
- 资助金额:
$ 25.2万 - 项目类别:
Defining Islet Heterogeneity Using Single Islet Transcriptomics
使用单胰岛转录组学定义胰岛异质性
- 批准号:
8812982 - 财政年份:2014
- 资助金额:
$ 25.2万 - 项目类别:
Pancreas Volume in Preclinical Type 1 Diabetes
临床前 1 型糖尿病的胰腺体积
- 批准号:
8644494 - 财政年份:2013
- 资助金额:
$ 25.2万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 25.2万 - 项目类别:
Standard Grant